Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
ATT
Abattis Bioceuticals
C$0.00
C$0.05
C$0.74
N/AN/A1.42 million shsN/A
BlackRock MuniYield Quality Fund III, Inc. stock logo
MYI
BlackRock MuniYield Quality Fund III
$10.38
+0.0%
$10.43
$9.98
$12.07
N/A0.57194,564 shs116,642 shs
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
ATT
Abattis Bioceuticals
0.00%0.00%0.00%0.00%0.00%
BlackRock MuniYield Quality Fund III, Inc. stock logo
MYI
BlackRock MuniYield Quality Fund III
-0.62%-1.28%+1.80%+0.10%-9.69%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
ATT
Abattis Bioceuticals
N/AN/AN/AN/AN/AN/AN/AN/A
BlackRock MuniYield Quality Fund III, Inc. stock logo
MYI
BlackRock MuniYield Quality Fund III
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
ATT
Abattis Bioceuticals
0.00
N/AN/AN/A
BlackRock MuniYield Quality Fund III, Inc. stock logo
MYI
BlackRock MuniYield Quality Fund III
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
ATT
Abattis Bioceuticals
N/AN/AN/AN/AN/AN/A
BlackRock MuniYield Quality Fund III, Inc. stock logo
MYI
BlackRock MuniYield Quality Fund III
$11.53MN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
ATT
Abattis Bioceuticals
N/AN/A0.00N/AN/AN/AN/AN/AN/A
BlackRock MuniYield Quality Fund III, Inc. stock logo
MYI
BlackRock MuniYield Quality Fund III
N/AN/A0.00N/AN/AN/AN/A10/1/2025 (Estimated)
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
ATT
Abattis Bioceuticals
N/AN/AN/AN/AN/A
BlackRock MuniYield Quality Fund III, Inc. stock logo
MYI
BlackRock MuniYield Quality Fund III
$0.393.76%N/AN/AN/A

Latest GHE, MYI, ATT, and WWH Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
8/5/2025
BlackRock MuniYield Quality Fund III, Inc. stock logo
MYI
BlackRock MuniYield Quality Fund III
monthly$0.05556.4%8/15/20258/15/20259/2/2025
7/3/2025
BlackRock MuniYield Quality Fund III, Inc. stock logo
MYI
BlackRock MuniYield Quality Fund III
monthly$0.05556.3%7/15/20257/15/20258/1/2025
6/4/2025
BlackRock MuniYield Quality Fund III, Inc. stock logo
MYI
BlackRock MuniYield Quality Fund III
monthly$0.05556.4%6/13/20256/13/20257/1/2025
(Data available from 1/1/2013 forward)

Institutional Ownership

CompanyInstitutional Ownership
ATT
Abattis Bioceuticals
N/A
BlackRock MuniYield Quality Fund III, Inc. stock logo
MYI
BlackRock MuniYield Quality Fund III
34.01%

Insider Ownership

CompanyInsider Ownership
ATT
Abattis Bioceuticals
N/A
BlackRock MuniYield Quality Fund III, Inc. stock logo
MYI
BlackRock MuniYield Quality Fund III
1.00%
CompanyEmployeesShares OutstandingFree FloatOptionable
ATT
Abattis Bioceuticals
N/AN/AN/ANot Optionable
BlackRock MuniYield Quality Fund III, Inc. stock logo
MYI
BlackRock MuniYield Quality Fund III
147,000N/AN/ANot Optionable

Recent News About These Companies

(MYI) Technical Pivots with Risk Controls
How to Take Advantage of moves in (MYI)
Trading (MYI) With Integrated Risk Controls
(MYI) Long Term Investment Analysis
Long Term Trading Analysis for (MYI)
Objective long/short (MYI) Report
BlackRock Investment Quality Municipal Trust Inc. (BKN)
When (MYI) Moves Investors should Listen
How the (MYI) price action is used to our Advantage
MYI: Buy The Discount For Rate-Cut Rally
BlackRock MuniYield Fund (MYD)
BlackRock S&P 500 Index V.I. Fund III

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines

Abattis Bioceuticals CNSX:ATT

Abattis Bioceuticals Corp. is a specialty biotechnology company. The Company aggregates, incubates, integrates and invests in the natural health product and botanical drug development industry. It operates through the segment of producing, licensing and marketing ingredients and formulas for use in the biopharma, nutraceutical, cosmetic and animal nutrition markets. The Company, through its subsidiaries, develops and commercializes natural health (nutraceutical) products, and conducts research and development to create plant-based (botanical) intellectual property and ingredients for the pharmaceutical and bioceutical markets, among others. It offers products and services, such as botanical blends and formulas; cannabidiol ingredients; functional foods and beverages, and analytical services. It is focused on creating botanical formulations, medical marijuana and specialized health products for pain caused by inflammation, and mental ailments.

BlackRock MuniYield Quality Fund III stock logo

BlackRock MuniYield Quality Fund III NYSE:MYI

$10.38 +0.01 (+0.05%)
As of 02:52 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

BlackRock MuniYield Quality Fund III, Inc. is a closed ended fixed income mutual fund launched by BlackRock, Inc. It is managed by BlackRock Advisors, LLC. The fund invests in fixed income markets. It invests primarily in a portfolio of long-term investment-grade municipal obligations exempt from federal income taxes. BlackRock MuniYield Quality Fund III, Inc. was formed in April 13, 1992 and is domiciled in United States.